Cvie Therapeutics Limited

Taïwan, Province de Chine

 
Quantité totale PI 8
Rang # Quantité totale PI 192 985
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 931 416

Brevets

Marques

3 0
4 0
1 0
0
 
Dernier brevet 2021 - 17beta-heterocyclyl-digitalis li...
Premier brevet 2006 - Crystalline rostafuroxin

Derniers inventions, produits et services

2019 Invention 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure. 4) linear or bra...
Invention 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure. 14144) linear or...
Invention 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure. Disclosed are co...
2015 Invention 5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and ...
2010 Invention Methods and systems for pharmacogenomic treatment of cardiovascular conditions. Methods and syste...
Invention 5-.beta., 14-.beta.-androstane derivatives useful for the treatment of proteinuria, glomeruloscle...
2008 Invention 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or...
2007 Invention Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular diso...
2006 Invention Crystalline rostafuroxin. New crystalline forms of 17β-(3-Furyl)-5-βandrostane-3β,14β,17α-triol a...